Cargando…
PRaG Therapy of Refractory Metastatic Gastric Cancer: A Case Report
Patients with metastatic gastric cancer had limited treatments and often had a somber prognosis, especially when patients were unable to tolerate high-intensity cytotoxic treatment due to poor physical condition or organ dysfunction after the failure of standard therapy. Here, we reported a metastat...
Autores principales: | Xu, Hong, Hong, Zhihui, Xu, Meiling, Kong, Yuehong, Ma, Yifu, Shan, Chanchan, Xing, Pengfei, Zhang, Liyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300850/ https://www.ncbi.nlm.nih.gov/pubmed/35874658 http://dx.doi.org/10.3389/fimmu.2022.926740 |
Ejemplares similares
-
PD-1 Inhibitor Combined With Radiotherapy and GM-CSF (PRaG) in Patients With Metastatic Solid Tumors: An Open-Label Phase II Study
por: Kong, Yuehong, et al.
Publicado: (2022) -
Prag Letter
por: Park, Roswell
Publicado: (1882) -
PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report
por: Yang, Jiabao, et al.
Publicado: (2023) -
Some Later Medieval Latin Medical MSS at Bern and Prag
por: Thorndike, Lynn
Publicado: (1936) -
Meta-research on pragmatism of randomized trials: rationale and design of the PragMeta database
por: Hirt, Julian, et al.
Publicado: (2023)